Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037315 (
sleep apnea
)
8,000
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Patients with obstructive
sleep apnoea
syndrome frequently have cognitive deficits, especially related to executive functions, which cannot be fully explained by daytime sleepiness and are partial irreversible after nasal continuous positive airway pressure treatment. The causal mechanism of these cognitive deficits is not yet known, but it has been proposed that they are associated with chemical and structural brain cell injury. The aim of this study was to investigate brain metabolism in patients with
sleep apnoea
syndrome. Twenty-two patients with severe
sleep apnoea
and 10 healthy volunteers of comparable age were studied using single voxel proton magnetic resonance spectroscopy. Magnetic resonance spectra were obtained from prefrontal cortex, parieto-occipital and frontal periventricular white matter.
N-acetylaspartate
-to-creatine and choline-to-creatine ratios were significantly lower in the frontal white matter of obstructive
sleep apnoea
patients when compared to controls. Absolute concentrations of
N-acetylaspartate
and choline were also significantly reduced in the frontal white matter of patients with
sleep apnoea
. Frontal lobe white matter lesions are known to be associated with cognitive executive dysfunction. The findings of this study may offer an explanation for the sometimes irreversible cognitive deficits associated with
sleep apnoea
.
...
PMID:Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study. 1557 42